Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market (2025-2031) | Companies, Size & Revenue, Forecast, Industry, Analysis, Share, Growth, Outlook, Trends, Segmentation, Competitive Landscape, Value

Market Forecast By Biomarker Type (Serum Biomarkers, Biomarker Panels, Fibrosis Biomarkers, Imaging Biomarkers, Others), By End User (Hospitals, Diagnostic Centers, Others) And Competitive Landscape
Product Code: ETC9517388 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Suriname Non-alcoholic Steatohepatitis (Nash) Biomarkers Market: Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, Suriname continued to import non-alcoholic steatohepatitis (NASH) biomarkers primarily from key countries such as the United States, Netherlands, Brazil, Peru, and the United Kingdom. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market with limited competition. The compound annual growth rate (CAGR) from 2020 to 2024 showed a decline of -22.78%, reflecting challenges in the market. Furthermore, the growth rate in 2024 dropped significantly by -60.7%, highlighting a potential slowdown in the importation of NASH biomarkers. Monitoring these trends is crucial for stakeholders in the industry to navigate market dynamics effectively.

Suriname Non-alcoholic Steatohepatitis (Nash) Biomarkers Market: Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Outlook
  • Market Size of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, 2024
  • Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenues & Volume for the Period 2021- 2031
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trend Evolution
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers and Challenges
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Price Trends
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Porter's Five Forces
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Life Cycle
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Biomarker Type for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Serum Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Biomarker Panels for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Fibrosis Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Imaging Biomarkers for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By End User for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Diagnostic Centers for the Period 2021- 2031
  • Historical Data and Forecast of Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume By Others for the Period 2021- 2031
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Import Export Trade Statistics
  • Market Opportunity Assessment By Biomarker Type
  • Market Opportunity Assessment By End User
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Top Companies Market Share
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Competitive Benchmarking By Technical and Operational Parameters
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Company Profiles
  • Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview

3.1 Suriname Country Macro Economic Indicators

3.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F

3.3 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle

3.4 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces

3.5 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F

3.6 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F

4 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Suriname

4.2.2 Growing awareness about the importance of early diagnosis and monitoring of NASH

4.2.3 Technological advancements in biomarker research for NASH

4.3 Market Restraints

4.3.1 Limited availability of specific biomarkers for accurately diagnosing NASH

4.3.2 High cost associated with biomarker development and testing

4.3.3 Regulatory challenges in the approval process for new biomarkers

5 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends

6 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types

6.1 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type

6.1.1 Overview and Analysis

6.1.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F

6.1.3 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F

6.1.4 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F

6.1.5 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F

6.1.6 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F

6.1.7 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

6.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User

6.2.1 Overview and Analysis

6.2.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F

6.2.4 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F

7 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics

7.1 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries

7.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries

8 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators

8.1 Number of research studies focused on NASH biomarkers in Suriname

8.2 Adoption rate of NASH biomarker testing by healthcare providers in Suriname

8.3 Average time taken for the development and validation of new NASH biomarkers

9 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment

9.1 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F

9.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F

10 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape

10.1 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024

10.2 Suriname Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All